PEPTONIC MEDICAL (28L) — Defensive Interval Ratio
PEPTONIC MEDICAL (28L) has a Defensive Interval Ratio of 48 days as of December 2023. Defensive assets of €4.13 Million (cash €-, short-term investments €-, receivables €4.13 Million) cover 48 days of daily cash needs of €86.07K/day. See 28L current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
PEPTONIC MEDICAL Defensive Interval Ratio (2021–2023)
This chart shows how PEPTONIC MEDICAL's Defensive Interval Ratio has evolved across 3 annual periods from 2021 to 2023. As of December 2023, the ratio stands at 48 days, meaning defensive assets of €4.13 Million can fund 48 days of operations without new revenue. See 28L equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for PEPTONIC MEDICAL (2021–2023)
The table below presents the year-by-year Defensive Interval Ratio for PEPTONIC MEDICAL from 2021 to 2023, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 28L market cap overview.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 48 days | €4.13 Million | €86.07K/day | €- | €- | ▼ -27 days |
| 2022 | 75 days | €7.24 Million | €96.07K/day | €- | €- | ▲ +15 days |
| 2021 | 60 days | €5.17 Million | €86.25K/day | €- | €- | — |